HUDSON, N.H., June 6, 2012 /PRNewswire/ -- Atrium Medical's
ClearWay™ local therapeutic infusion catheter has been selected as
one of this year's twenty medical innovations by clinicians and
other members of the Premier healthcare alliance, a hospital-owned
performance improvement alliance of more than 2,600 hospitals and
84,000 other care sites.
Atrium Medical Corporation, a business unit of MAQUET
Cardiovascular, showcased the ClearWay before thousands of
healthcare representatives at Premier's fourth annual Innovation
Celebration. This yearly conference recognizes advancements in
healthcare, highlighting industry suppliers committed to innovation
and improved patient outcomes.
Selection criteria included the uniqueness of the product, its
ability to have an impact on an unmet medical need and its
potential to positively impact patient care.
Innovations were shared during Premier's 2012 Breakthroughs
Conference and Exhibition in Nashville,
Tenn. on June 5. Approximately
4,000 healthcare providers and experts attended the conference.
Atrium's ClearWay™ local therapeutic infusion catheter is a new
atraumatic drug delivery balloon. The ClearWay catheter provides
super selective, local intra-vessel infusion of medication,
allowing more medication to act locally at a higher concentration
and for a longer period of time to maximize its therapeutic effect
on the occluding blood clot or diseased vessel. The balloon
controllably engages the vessel wall to gently and atraumatically
occlude blood flow during drug infusion thus providing drug
concentrations hundreds of times greater at the site of local
delivery than traditional systemic drug administration. ClearWay
offers physicians a simple and highly effective method to maximize
drug availability, concentration, and residence time in order to
greatly enhance the desired therapeutic effect. ClearWay is
available in both rapid exchange (RX) and over the wire (OTW)
platforms and is available in balloon diameter ranges of 1.0 mm to
8.0 mm and balloon lengths ranging from 10 mm to 50 mm.
"All of us at Atrium Medical take extraordinary pride in the
innovative design and manufacture of our products and the quality
service we provide to improve the level of patient care to all of
our Premier members," said Michael
DuPont, Vice President of Marketing, Atrium Medical
Corporation.
"Those who attend and participate in the Innovation Celebration
share Premier's commitment to providing innovative, valuable
products to our members that impact healthcare's safety, quality
and cost," said Durral Gilbert,
senior vice president, Supply Chain Emerging Services, Premier.
"These new innovations will truly benefit people across the nation
as healthcare providers continue to improve care."
About the Premier healthcare alliance, Malcolm Baldrige
National Quality Award recipient
Premier is a performance improvement alliance of more than 2,600
U.S. hospitals and 84,000-plus other healthcare sites using the
power of collaboration to lead the transformation to high quality,
cost-effective care. Owned by hospitals, health systems and other
providers, Premier maintains the nation's most comprehensive
repository of clinical, financial and outcomes information and
operates a leading healthcare purchasing network. A world leader in
helping deliver measurable improvements in care, Premier has worked
with the Centers for Medicare & Medicaid Services and the
United Kingdom's National Health
Service North West to improve hospital performance. Headquartered
in Charlotte, N.C., Premier also
has an office in Washington.
http://www.premierinc.com. Stay connected with Premier on Facebook,
Twitter and YouTube.
About Atrium Medical Corporation
Atrium Medical Corporation's vast expertise in medical device
technologies for the treatment of coronary and vascular disease,
chest trauma, hernia and soft tissue injury has brought a number of
breakthrough advances in several diversified healthcare markets
including interventional cardiology and radiology, chest trauma
care and thoracic drainage, vascular surgery, and general surgery.
Maintaining a commitment to the latest ISO13485 Quality Standards,
state-of-the-art manufacturing and automation, cell biology and
biomaterial discovery programs, Atrium continues to excel in those
healthcare segments that require more advanced surgical
intervention for improvements in patient outcomes. Atrium is a
business unit of MAQUET Cardiovascular, a member of the GETINGE
GROUP of companies. For more information please visit
www.atriummed.com.
About MAQUET
As a trusted partner for hospitals and clinicians since 1838,
MAQUET is a global leader in medical systems that advance surgical
interventions, cardiovascular procedures and critical care. MAQUET
develops and designs innovative products and therapeutic
applications for the operating room, hybrid OR/cath lab, intensive
care unit and patient transport within acute care hospitals,
improving outcomes and quality of life for patients.
Cardiovascular specialties include intra-aortic balloon
counterpulsation (IABC) therapy for cardiac assist; coronary artery
bypass surgery; aortic and peripheral vascular surgery; and
extracorporeal circulation.
The Critical Care portfolio includes market-leading intensive
care ventilators and anesthesia machines.
MAQUET also equips Surgical Workplaces with critical
infrastructure such as flexible room design for OR and ICU; OR
tables; lights and ceiling supply units; and OR integration for
image data management.
MAQUET is a subsidiary of the publicly listed Swedish GETINGE
GROUP. In 2011, MAQUET generated nearly 1.4
billion Euro which is more than half of the Group's annual
revenue of 2.4 billion Euros. The
GETINGE Group has 13,000 employees worldwide, including around
6,000 MAQUET employees in 50 international sales and service
organizations, as well as a network of more than 280 sales
representatives. For more information please visit www.maquet.com
and www.getingegroup.com.
SOURCE Atrium Medical Corporation
